Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
NCT: NCT05674240 · COMPLETED
Publicidade
Resumo breve
This Registry study will prospectively evaluate the differences in treatment outcomes in terms of pain intensity, pain interference, concomitant medication use, health-related quality of life, opioid adverse effects, and healthcare utilization between targeted drug delivery and conservative medication management only groups.
Fonte oficial
Ver no ClinicalTrials.gov →Dados provenientes da API do ClinicalTrials.gov. Para consultar o estado mais recente, veja o registo oficial.